Myolyn, LLC

Medical device company · Gainesville, Florida, United States

Myolyn, LLC is a medical device company headquartered in Gainesville, Florida, United States. Its earliest recorded incorporation is in 2013. The US FDA lists 1 medical device site registered to the company, with devices in neurology. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $212,235 in total, most recently in 2020. It has reported private securities offerings to the US SEC, most recently $837,500 sold in a notice filed in 2017.

www.myolyn.comProfile compiled from public records. Is this your company? Request a correction or update

Myolyn at a glance

Typemedical device company
HeadquartersGainesville, Florida, United States
Earliest incorporation on record2013
FDA-registered sites1
Employees (self-reported, 2020)9
SEC CIK1637063

What does Myolyn do?

Medical specialties of its FDA-listed devices

Neurology

Device types listed with the FDA

Stimulator, neuromuscular, external functional

US government research funding

1 SBIR/STTR small-business research award from US health agencies, $212,235 in total (2020). NIH funding came from the National Institute of Child Health and Human Development.

Private fundraising reported to the SEC

3 Form D notices; the most recent reported $837,500 sold (2017).

Where is Myolyn located?

Headquarters: Gainesville, Florida, United States

  • Gainesville, FloridaMyolyn, Inc · FDA device site

Frequently asked questions about Myolyn

Where is Myolyn headquartered?

Myolyn, LLC is headquartered in Gainesville, Florida, United States.

What does Myolyn do?

Myolyn, LLC is a medical device company. Its FDA-listed medical devices fall under neurology.

When was Myolyn founded?

The earliest incorporation on record for Myolyn, LLC is in 2013, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-25. Data licences